SNPS.NASDAQSynopsys INC

Form 4: Synopsys Chief Revenue Officer Executes Pre-Planned Stock Sales and Option Exercises

Sentiment:

Insider Transaction Report


Synopsys Inc.'s Chief Revenue Officer, Richard S. Mahoney, engaged in pre-planned transactions on June 18, 2025, exercising stock options and selling common stock under a Rule 10b5-1 trading plan.

Summary

  • Richard S. Mahoney, Chief Revenue Officer of Synopsys Inc. (SNPS), executed several transactions on June 18, 2025.
  • These transactions were conducted under a Rule 10b5-1 trading plan that was adopted on September 13, 2024.
  • Mahoney sold 4,869 shares of common stock at a weighted average price of $471.1892 per share.
  • He exercised 2,949 non-qualified stock options with an exercise price of $319.2 per share and subsequently sold these 2,949 shares at a weighted average price of $471.2728 per share.
  • Additionally, he exercised 1,192 non-qualified stock options with an exercise price of $354.45 per share and subsequently sold these 1,192 shares at a weighted average price of $471.1758 per share.
  • Following these transactions, Mahoney's direct beneficial ownership of common stock is 1,485 shares, and he holds 5,898 and 4,173 derivative securities (non-qualified stock options) respectively.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can be a negative signal, the fact that these sales were pre-planned under a 10b5-1 plan mitigates concerns. The exercise of options also indicates the officer is realizing value from their compensation.

Positives

  • The exercise of stock options indicates that the officer sees value in exercising them, suggesting confidence in the company's stock price being above the exercise price.
  • The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests the sales were not based on new, non-public information.

Negatives

  • The sale of a significant number of shares by a Chief Revenue Officer could be perceived negatively by some investors, as it reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions for an executive at Synopsys, a leading company in electronic design automation (EDA) and semiconductor IP. Such transactions are common for executives managing their personal portfolios and compensation, especially when executed under pre-arranged 10b5-1 plans, and do not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

  • Shareholders: The sale of shares by a key executive, even if pre-planned, might be viewed with slight caution, though the 10b5-1 plan mitigates concerns about immediate negative implications. The exercise of options indicates the executive is realizing value from their compensation, which is a normal part of executive pay structures.

Key Dates

DateDescription
05/31/2023Date when 1/4 of the 2,949 non-qualified stock options became exercisable.
02/17/2024Date when 1/4 of the 1,192 non-qualified stock options became exercisable.
09/13/2024Date the Rule 10b5-1 trading plan was adopted.
06/18/2025Date of the reported stock transactions (sales and option exercises).
06/20/2025Date the Form 4 was signed by the Power of Attorney.
05/31/2029Expiration date for 2,949 non-qualified stock options.
02/17/2030Expiration date for 1,192 non-qualified stock options.

Recommendation

hold

Keywords

Synopsys, SNPS, SEC Form 4, Insider Trading, Stock Options, Rule 10b5-1, Share Sale, Executive Compensation, Richard S. Mahoney, Chief Revenue Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.